These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6605749)

  • 1. Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin-2 production.
    Sibbitt WL; Likar L; Spellman CW; Bankhurst AD
    Arthritis Rheum; 1983 Nov; 26(11):1316-20. PubMed ID: 6605749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
    Sibbitt WL; Mathews PM; Bankhurst AD
    J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
    Sibbitt WL; Mathews PM; Bankhurst AD
    Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interleukin 2 in inducing normalization of natural killer activity in systemic lupus erythematosus.
    Gaspar ML; Alvarez-Mon M; Gutiérrez C
    Clin Immunol Immunopathol; 1988 Nov; 49(2):204-14. PubMed ID: 3139345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus.
    Tsokos GC; Smith PL; Christian CB; Lipnick RN; Balow JE; Djeu JY
    Clin Immunol Immunopathol; 1985 Mar; 34(3):379-86. PubMed ID: 3156017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-alpha regulation of lymphocyte function in systemic lupus erythematosus.
    Sibbitt WL; Froelich CJ; Bankhurst AD
    Clin Immunol Immunopathol; 1984 Jul; 32(1):70-80. PubMed ID: 6733982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokines in autoimmunity: relationship between interleukin-2 and interferon-gamma production in systemic lupus erythematosus.
    Sibbitt WL; Kenny C; Spellman CW; Ley KD; Bankhurst AD
    Clin Immunol Immunopathol; 1984 Aug; 32(2):166-73. PubMed ID: 6428789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Interleukin-15 on CD11b, CD54, and CD62L Expression on Natural Killer Cell and Natural Killer T-Like Cells in Systemic Lupus Erythematosus.
    Lin SJ; Chen JY; Kuo ML; Hsiao HS; Lee PT; Huang JL
    Mediators Inflamm; 2016; 2016():9675861. PubMed ID: 27847409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
    Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
    Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independence of depressed lectin-dependent cell-mediated cytotoxicity from interleukin 2 production in patients with systemic lupus erythematosus.
    Perl A; González-Cabello R; Onody K; Bodó I; Gergely P
    Clin Exp Immunol; 1986 Aug; 65(2):286-92. PubMed ID: 3491706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
    Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
    Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of frequency and expression level of CD161 in CD8
    Park Y; Lim J; Kim SY; Kwon GC; Koo SH; Kim J
    Microbiol Immunol; 2020 Jul; 64(7):532-539. PubMed ID: 32343447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells in connective tissue disorders.
    Sibbitt WL; Bankhurst AD
    Clin Rheum Dis; 1985 Dec; 11(3):507-21. PubMed ID: 3907953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC.
    Ytterberg SR; Huard TK; Schnitzer TJ
    J Rheumatol; 1983 Dec; 10(6):906-12. PubMed ID: 6663595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.
    Ytterberg SR; Schnitzer TJ
    Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family study of natural killer cell activity in C1q-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and C1q deficiency.
    Tóth J; Starsia Z; Buc M; Stefanovic J
    Immunobiology; 1989 Nov; 180(1):47-54. PubMed ID: 2625354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T
    J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: CD4+ T Cells From Patients With Systemic Lupus Erythematosus Respond Poorly to Exogenous Interleukin-2.
    Comte D; Karampetsou MP; Kis-Toth K; Yoshida N; Bradley SJ; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2017 Apr; 69(4):808-813. PubMed ID: 27992687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.